Multi-Omics Identification of UBE2C as a Prognostic Biomarker and Therapeutic Target Linked to Topotecan Sensitivity in Cervical Cancer

Emmanuel Naveen Raj, Chia-Jung Li, Shih-Hsuan Cheng, Su-Boon Yong, Zhi-Hong Wen, An-Jen Chiang

Open source

DOI
10.32604/or.2026.079551
Published
2026
Container
Oncology Research
Publisher
Tech Science Press
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.32604/or.2026.079551,
  title = {Multi-Omics Identification of UBE2C as a Prognostic Biomarker and Therapeutic Target Linked to Topotecan Sensitivity in Cervical Cancer},
  author = {Emmanuel Naveen Raj and Chia-Jung Li and Shih-Hsuan Cheng and Su-Boon Yong and Zhi-Hong Wen and An-Jen Chiang},
  year = {2026},
  journal = {Oncology Research},
  doi = {10.32604/or.2026.079551},
  url = {https://doi.org/10.32604/or.2026.079551}
}

RIS

TY  - JOUR
TI  - Multi-Omics Identification of UBE2C as a Prognostic Biomarker and Therapeutic Target Linked to Topotecan Sensitivity in Cervical Cancer
AU  - Emmanuel Naveen Raj
AU  - Chia-Jung Li
AU  - Shih-Hsuan Cheng
AU  - Su-Boon Yong
AU  - Zhi-Hong Wen
AU  - An-Jen Chiang
PY  - 2026
JO  - Oncology Research
DO  - 10.32604/or.2026.079551
UR  - https://doi.org/10.32604/or.2026.079551
ER  - 

APA

Raj, E. N., Li, C., Cheng, S., Yong, S., Wen, Z., & Chiang, A. (2026). Multi-Omics Identification of UBE2C as a Prognostic Biomarker and Therapeutic Target Linked to Topotecan Sensitivity in Cervical Cancer. Oncology Research. https://doi.org/10.32604/or.2026.079551

Source records